scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1033592844 |
P356 | DOI | 10.1038/LEU.2016.383 |
P698 | PubMed publication ID | 28017968 |
P50 | author | Roberto Piva | Q37374816 |
Tiziana Vaisitti | Q55167915 | ||
Francesco Neri | Q56812779 | ||
Simona Cignetto | Q57070667 | ||
P2093 | author name string | N Vitale | |
G Gaidano | |||
J Allan | |||
D Incarnato | |||
D Rossi | |||
B Gizdic | |||
C Bologna | |||
E Mereu | |||
F Arruga | |||
F Diop | |||
G Garaffo | |||
K Gizzi | |||
M Coscia | |||
R Buonincontri | |||
R R Furman | |||
S Deaglio | |||
S Oliviero | |||
S Serra | |||
P2860 | cites work | Regulation of STAT3-mediated signaling by LMW-DSP2 | Q24320250 |
Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution | Q26823586 | ||
From fly wings to targeted cancer therapies: a centennial for notch signaling | Q27004534 | ||
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation | Q27851655 | ||
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. | Q27853022 | ||
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia. | Q27853333 | ||
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia | Q28394721 | ||
CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs | Q28594485 | ||
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia | Q29614659 | ||
JNK pathway-associated phosphatase dephosphorylates focal adhesion kinase and suppresses cell migration. | Q33648402 | ||
DNMT3A in haematological malignancies | Q34463554 | ||
Promoter hypermethylation of the phosphatase DUSP22 mediates PKA-dependent TAU phosphorylation and CREB activation in Alzheimer's disease | Q34522096 | ||
DUSP22/LMW-DSP2 regulates estrogen receptor-alpha-mediated signaling through dephosphorylation of Ser-118. | Q34612201 | ||
Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression | Q34998866 | ||
The Notch signalling system: recent insights into the complexity of a conserved pathway | Q35206852 | ||
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL | Q35794466 | ||
CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia | Q37113435 | ||
CCR7 expression alters memory CD8 T-cell homeostasis by regulating occupancy in IL-7- and IL-15-dependent niches | Q37126820 | ||
Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia | Q37216335 | ||
Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome | Q37246532 | ||
Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups | Q38511275 | ||
Richter syndrome: pathogenesis and management | Q38797098 | ||
Mutations driving CLL and their evolution in progression and relapse | Q39714436 | ||
Ablation of Stat3 by siRNA alters gene expression profiles in JEG-3 cells: a systems biology approach | Q39823459 | ||
De novo DNA methyltransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2'-deoxycytidine. | Q40453633 | ||
Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. | Q40683787 | ||
Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients | Q40881581 | ||
Protein kinase CK2 regulates the dimerization of histone deacetylase 1 (HDAC1) and HDAC2 during mitosis | Q42144052 | ||
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients | Q43555954 | ||
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism | Q43607424 | ||
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia | Q46339557 | ||
CIP4 controls CCL19-driven cell steering and chemotaxis in chronic lymphocytic leukemia. | Q51019240 | ||
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation. | Q52931736 | ||
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. | Q53259951 | ||
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting. | Q53271932 | ||
HDAC1/DNMT3A-containing complex is associated with suppression of Oct4 in cervical cancer cells. | Q53854927 | ||
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features. | Q54409071 | ||
Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia. | Q54672999 | ||
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells | Q81974229 | ||
P433 | issue | 9 | |
P921 | main subject | chronic lymphocytic leukemia | Q1088156 |
lymphocyte | Q715347 | ||
leukemia | Q29496 | ||
P304 | page(s) | 1882-1893 | |
P577 | publication date | 2016-12-26 | |
P1433 | published in | Leukemia | Q6534498 |
P1476 | title | Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22. | |
P478 | volume | 31 |